| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |